Clinical trial
Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative…
NCT06923787 · Institute of Oncology Ljubljana, Other · Recruiting
Key facts
| NCT number | NCT06923787 |
|---|---|
| Title | Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study |
| Official title | Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study |
| Acronym | PILDI |
| Lead sponsor | Institute of Oncology Ljubljana, Other |
| Status | Recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colon Cancer |
| Intervention type | Drug |
| Interventions | Lidocaine, Placebo |
| Enrollment | 100 |
| Start date | Feb 3, 2026 |
| Primary completion | Jul 1, 2027 |
| Completion | Jul 1, 2028 |
| First posted | Apr 11, 2025 |
| Last update posted | Feb 5, 2026 |
| Countries | Slovenia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: